NCT05950087View on ClinicalTrials.gov

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2026

Conditions
Locally Advanced Cervical Cancer
Interventions
OTHER

Concurrent chemoradiotherapy

Concurrent chemoradiotherapy

Trial Locations (1)

Unknown

RECRUITING

Yong Li, Guiyang

All Listed Sponsors
lead

Guizhou Provincial People's Hospital

OTHER